Abstract:Background: The growth in the capabilities of telehealth have made it possible to identify individuals with a higher risk of uncontrolled diabetes and provide them with targeted support and resources to help them manage their condition. Thus, predictive modeling has emerged as a valuable tool for the advancement of diabetes management. Objective: This study aimed to conceptualize and develop a novel machine learning (ML) approach to proactively identify participants enrolled in a remote diabetes monitoring program (RDMP) who were at risk of uncontrolled diabetes at 12 months in the program. Methods: Registry data from the Livongo for Diabetes RDMP were used to design separate dynamic predictive ML models to predict participant outcomes at each monthly checkpoint of the participants' program journey (month-n models) from the first day of onboarding (month-0 model) up to the 11th month (month-11 model). A participant's program journey began upon onboarding into the RDMP and monitoring their own blood glucose (BG) levels through the RDMP-provided BG meter. Each participant passed through 12 predicative models through their first year enrolled in the RDMP. Four categories of participant attributes (ie, survey data, BG data, medication fills, and health signals) were used for feature construction. The models were trained using the light gradient boosting machine and underwent hyperparameter tuning. The performance of the models was evaluated using standard metrics, including precision, recall, specificity, the area under the curve, the F1-score, and accuracy. Results: The ML models exhibited strong performance, accurately identifying observable at-risk participants, with recall ranging from 70% to 94% and precision from 40% to 88% across the 12-month program journey. Unobservable at-risk participants also showed promising performance, with recall ranging from 61% to 82% and precision from 42% to 61%. Overall, model performance improved as participants progressed through their program journey, demonstrating the importance of engagement data in predicting long-term clinical outcomes. Conclusions: This study explored the Livongo for Diabetes RDMP participants' temporal and static attributes, identification of diabetes management patterns and characteristics, and their relationship to predict diabetes management outcomes. Proactive targeting ML models accurately identified participants at risk of uncontrolled diabetes with a high level of precision that was generalizable through future years within the RDMP. The ability to identify participants who are at risk at various time points throughout the program journey allows for personalized interventions to improve outcomes. This approach offers significant advancements in the feasibility of large-scale implementation in remote monitoring programs and can help prevent uncontrolled glycemic levels and diabetes-related complications. Future research should include the impact of significant changes that can affect a participant's diabetes management.

Identifying Prediabetes in Canadian Populations Using Machine Learning

Predicting Diabetes in Canadian Adults Using Machine Learning

Development and Validation of Machine Learning Models for Identifying Prediabetes and Diabetes in Normoglycemia

Nuclear magnetic resonance-based metabolomics with machine learning for predicting progression from prediabetes to diabetes

Proactive Identification of Patients with Diabetes at Risk of Uncontrolled Outcomes during a Diabetes Management Program: Conceptualization and Development Study Using Machine Learning

Exploring Prediabetes Pathways Using Explainable AI on Data from Electronic Medical Records

PREDICTIVE MODELLING FOR DIABETES USING MACHINE LEARNING

Machine learning based predictive model of Type 2 diabetes complications using Malaysian National Diabetes Registry: A study protocol

Predicting Depression Among Canadians At-Risk or Living with Diabetes Using Machine Learning

Machine Learning-Based Metabolic Syndrome Identification

Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics

Development and Validation of a Machine Learning Model Using Administrative Health Data to Predict Onset of Type 2 Diabetes

A machine learning tool for identifying patients with newly diagnosed diabetes in primary care

Title : A Machine Learning-based Framework to Identify Type 2 Diabetes through

Machine Learning Approach with Harmonized Multinational Datasets for Enhanced Prediction of Hypothyroidism in Patients with Type 2 Diabetes

Using Machine Learning Techniques to Identify Key Risk Factors for Diabetes and Undiagnosed Diabetes

First Experiences with the Identification of People at Risk for Diabetes in Argentina using Machine Learning Techniques

A Machine Learning Approach for Prediction of Diabetes Mellitus

Comparative analysis of predictive machine learning algorithms for diabetes mellitus

Predicting the 2-Year Risk of Progression from Prediabetes to Diabetes Using Machine Learning among Chinese Elderly Adults